Bank Of Montreal Stock Price, News & Analysis

BMO announced the redemption of its MicroSectors FANG+ Index 3× Leveraged ETNs (FNGA) and reminded investors about the availability of its replacement product, FNGB ETNs. The Call Measurement Period for FNGA will run from May 2-8, 2025, with the Call Settlement Date expected on May 15, 2025. The final trading day for FNGA is expected to be May 14, 2025. The new FNGB ETNs, launched on February 19, 2025, offer 3x leveraged exposure to the NYSE FANG+ Index with a discounted fee rate of 0.35% per annum until August 19, 2025, after which it will increase to 0.95%. Both ETNs track an equally-weighted index of 10 high-growth tech stocks, providing daily resetting leverage designed for sophisticated investors' short-term trading strategies.

BMO has announced the redemption of its MicroSectors™ FANG+™ Index 3× Leveraged ETNs (FNGA) and reminded investors about the availability of its replacement product, the FNGB ETNs.

The FNGA ETNs will be redeemed on May 15, 2025, with the last trading day expected to be May 14, 2025. BMO is exercising this call right due to increased costs associated with supporting the leverage, making current fees no longer reflective of market conditions.

The new FNGB ETNs, trading under ticker 'FNGB' since February 20, 2025, offers similar 3x leveraged exposure to the NYSE FANG+® Index. It features a discounted Daily Investor Fee of 0.35% per annum until August 19, 2025, after which it will increase to 0.95% per annum.

Bank of Montreal (BMO) held its Annual Meeting of Shareholders on April 11, 2025, where shareholders elected 13 directors to the company's board. The election results showed strong shareholder support, with all nominees receiving over 94% approval.

Notable results include Brian McManus receiving the highest approval rate at 99.69% of votes, while George A. Cope received the lowest but still strong support at 94.93%. The voting results demonstrated particularly strong confidence in several directors, including Stephen Dent (99.62%), David Harquail (99.61%), and Hazel Claxton (99.55%).

BMO is set to host its second annual Obesity Summit on March 25, 2025, in New York, focusing on the expanding $150 billion obesity therapies market. The summit will bring together healthcare industry experts and leaders to examine trends in metabolic disease and drug therapies.

The event features prominent companies including Altimmune, Amgen, Corbus Pharmaceuticals, Eli Lilly, FlyteHealth, Novo Nordisk, Roman Health, Scholar Rock, and Structure Therapeutics. Participants will explore advances in GLP-1 drug therapies with insights from pharmacy benefit managers, patients, and providers.

The summit's agenda includes fireside chats, expert panels, and presentations featuring BMO Sr. Biotechnology & Pharmaceuticals Analyst Evan Seigerman, FlyteHealth Co-Founder Dr. Katherine Saunders, and Dr. Louis J. Aronne, Sanford I. Weill Professor of Metabolic Research. Key topics include care delivery, emerging technologies, coverage and access, and patient insights on GLP-1+ therapy.

BMO (TSX: BMO) (NYSE: BMO) has announced the filing of its 2025 Notice of Annual Meeting of Shareholders and Management Proxy Circular with securities regulators. The Annual Meeting will take place on Friday, April 11, 2025, at 9:30 a.m. EDT.

Key highlights include:

• The Management Proxy Circular contains essential shareholder voting information and meeting participation details
• Documents are available on BMO's Annual Meeting website, Computershare Trust Company's platform, SEDAR+, and EDGAR
• Shareholders can participate through live webcast, in-person attendance, or teleconference

Additionally, BMO will release its 2024 Sustainability and Climate Reporting on March 12, which will include Public Accountability Statements. This report will address regulatory requirements and emerging sustainability frameworks, including OSFI's Guideline B-15 on climate risk management and Sustainability Accounting Standards Board standards.

Bank of Montreal (TSX: BMO) (NYSE: BMO) announced that its Board of Directors has declared a quarterly dividend of $1.59 per share on common shares for Q2 2025, unchanged from the previous quarter. The board also declared dividends on various preferred shares: $0.190875 per share on Class B Series 33, $0.426 per share on Class B Series 44, $36.865 per share on Class B Series 50, and $35.285 per share on Class B Series 52.

The common share dividend is payable on May 27, 2025, to shareholders of record on April 29, 2025, while preferred share dividends are payable on May 26, 2025, to shareholders of record on the same date. All dividends are designated as "eligible" for Canadian tax purposes.

Shareholders can reinvest their cash dividends in BMO common shares through the Shareholder Dividend Reinvestment and Share Purchase Plan, with additional shares purchased on the open market without a discount.

BMO Financial Group reported strong first quarter 2025 financial results with net income of $2,138 million, up from $1,292 million in Q1 2024. Earnings per share (EPS) increased to $2.83 from $1.73 year-over-year. On an adjusted basis, net income was $2,289 million with EPS of $3.04, compared to $1,893 million and $2.56 in the prior year.

The bank delivered broad-based revenue growth across all operating groups, with particularly strong performance in BMO Capital Markets where net income increased 49% to $587 million. BMO Wealth Management saw a 53% increase in net income to $369 million.

The provision for credit losses rose to $1,011 million from $627 million in the prior year, primarily due to higher provisions in Commercial Banking and Canadian unsecured consumer lending.

BMO announced a quarterly dividend of $1.59 per common share, a 5% increase from the prior year. During the quarter, the bank purchased 1.2 million common shares for cancellation under its normal course issuer bid. The Common Equity Tier 1 (CET1) Ratio remained strong at 13.6%.

BMO Capital Markets is set to host its 34th annual Global Metals, Mining & Critical Minerals Conference from February 23-26, 2025, in Hollywood, Florida. The event will bring together more than 1,400 global industry leaders and institutional investors to discuss key themes including the impact of global events on commodities and capital markets, and sector evolution.

The conference will feature keynote presentations and panels with industry leaders, including presentations from major companies such as Agnico Eagle Mines, BHP, Rio Tinto, Vale SA, and numerous others. BMO's research analysts will be available for media interviews throughout the event.

Alan Tannenbaum, CEO and Group Head of BMO Capital Markets, emphasized the bank's century-long leadership in the metals and mining industry, while Co-Heads of Global Metals & Mining, Ilan Bahar and Jamie Rogers, highlighted the conference's importance in connecting industry peers and evaluating market opportunities.

BMO has joined the IBM Quantum Network, becoming the first Canadian bank to access IBM's advanced quantum computing infrastructure. This strategic move, announced on February 6, 2025, aligns with BMO's Digital First strategy to enhance its technological capabilities and deliver improved outcomes for customers and clients.

The partnership will enable BMO to develop and implement quantum-powered solutions across its operations, focusing on:

• Accelerating new approaches to help clients prosper
• Supporting business growth
• Optimizing investment portfolio strategies
• Developing enhanced risk management solutions

Through the IBM Quantum Network, BMO gains access to learning resources, experts, and collaborative events aimed at advancing quantum utility in financial services.